Kit for nucleic acid combined detection of influenza virus A, influenza virus B and respiratory syncytial virus
A technology of influenza B virus and influenza A virus, which is applied in the field of joint detection kits for influenza A, influenza B virus and respiratory syncytial virus nucleic acid, can solve the problem of losing the ability to be re-amplified, and there is no respiratory syncytial virus Combined detection of fluorescent PCR detection kits, false positives and other issues, to achieve the effects of short amplification time, prevention of multiple operation contamination, and simple steps
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0042] Example 1 A combined detection kit for influenza A, B and respiratory syncytial virus nucleic acid
[0043] 1. Extraction of Respiratory Virus Nucleic Acid
[0044] Nucleic acid was extracted from human nasopharyngeal swab samples using the magnetic bead purification reagent produced by Shanghai Fosun Changzheng Medical Science Co., Ltd.
[0045] 2. Reverse transcription and fluorescent RT-PCR amplification (50 μl system per person)
[0046] [0046] RT-PCR reaction solution [0047] 25 μl [0048] RT-PCR Enzyme Mix [0049] 1 μl [0050] Respiratory virus primer probe [0051] 4 μl [0052] template [0053] 20 μl [0054] Reaction volume: [0055] 50 μl
[0047] b. One-step RT-PCR reaction procedure:
[0048] [1]50℃25min
[0049] [2]95℃5min
[0050] [3]95℃15s
[0051] [4]60℃50s
[0052] [5]Goto[4], 45cycles
[0053] In the fifth step, the fluorescence signals of FAM, HEX, CY3 and CY5 channels are collected.
[00...
Embodiment 2
[0061] Example 2 clinical testing
[0062] Using the above method, 50 cases of clinical samples were qualitatively detected by fluorescent PCR, including 15 cases of influenza A virus patients, with a positive detection rate of 30%; 4 cases of influenza B virus patients, with a positive detection rate of 8%; respiratory syncytial virus There were 12 patients, and the positive rate was 24%. The detection method and kit of the present invention have strong specificity, high sensitivity, simple operation and high repeatability, and can qualitatively identify influenza A virus, influenza B virus and respiratory syncytial virus in human nasopharyngeal swab samples , Detection. The present invention uses the magnetic bead method purification reagent produced by Shanghai Fosun Changzheng Medical Science Co., Ltd. to extract nucleic acid from human nasopharyngeal swab samples, thereby ensuring the purity of the template. At the same time, using one-step fluorescent RT-PCR technolo...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com